论文部分内容阅读
顽固性心衰患者通常需长期静脉应用利尿剂治疗,因而并发症较多,医疗费用昂贵,且给日常生活带来诸多不便.为解决上述弊端,作者对12例依赖静滴利尿剂,等待心脏移植的顽固性心衰患者,尝试性门诊给予利尿剂口服获得良好效益。 12例患者,年龄26—60岁(平均51岁),心脏功能Ⅳ级(纽约心脏学会).其中5例为晚期缺血性心脏病;5例为原发扩张型心肌病;2例为晚期心脏瓣膜病,经瓣膜置换术后心脏机能低下.所有患者在家中接受华法令、地高辛、巯甲丙脯酸和速尿(160—300毫克/天)口服.起初每日至少需静脉
Patients with refractory heart failure often need long-term intravenous diuretic therapy, thus more complications, high medical costs and inconvenience to daily life.In order to solve the above drawbacks, the author of 12 cases of intravenous diuretics, waiting for the heart Transplanted patients with refractory heart failure, trial out-patient diuretic oral administration of good results. Twelve patients, aged 26-60 years (mean 51 years) and cardiac function class IV (New York Heart Association), 5 were late ischemic heart disease, 5 were primary dilated cardiomyopathy, and 2 were late Cardiac valvular disease, heart failure after valvular replacement All patients received oral warfarin, digoxin, captopril and furosemide (160-300 mg / day) orally at home At first, daily intravenous